Ces dernières semaines, de nouveaux articles signés par les équipes du CRCM ont été publiés dans des revues scientifiques internationales reconnues.

Vous pouvez découvrir ci-dessous l’ensemble des publications récentes.

Équipe Nunès / Devillier

➡️  A comprehensive review of mechanisms underlying resistance to immune checkpoint inhibitors.

➡️  Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomy.

Équipe Pasquier / André

➡️  Building a new arsenal: repurposed drugs and metronomic chemotherapy against medulloblastoma.

Équipe Benzekry / Ciccolini

➡️ Model-Driven Optimization of Subcutaneous Polymer Prodrugs Achieves Cancer Remission in Mice.

Équipe Mamessier / Bertucci

➡️ Follicular and follicle center-cell lymphomas: A family between kinship and diversity.

➡️ Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value.

➡️ [Sugemalimab as monotherapy for unresectable stage III non-small cell lung cancer with PD-L1 expression≥1%, without oncogenic driver alterations and without progression after chemoradiation].

Équipe Modesti

➡️ Human DNA-PKcs promotes broken DNA-end structure independence during NHEJ.

Équipe Coulon

➡️ Aneuploidy alleviates the cell proliferation defect caused by mutations affecting origin licensing in Saccharomyces cerevisiae.